IPO round-up: Lantheus shelves $125m float; Catalent raises $871m
This article was originally published in Clinica
Lantheus Holdings has postponed its planned $125m initial public offering, blaming poor market conditions. The firm, the parent company of imaging agent specialist Lantheus Medical Imaging, said in June that it was planning to go public, but did not give any pricing details. It had hoped to list on the Nasdaq under the ticker symbol LNTH.